Drug development in cancer research is exploring several promising areas, including the use of small molecule inhibitors, monoclonal antibodies, and antibody-drug conjugates. Researchers are also studying the potential of natural compounds and repurposing existing drugs for cancer treatment. Clinical trials are essential to evaluate the safety and efficacy of new drugs.
